CD19x22 CAR T / University of Colorado  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CD19x22 CAR T / University of Colorado
NCT05098613: Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Recruiting
1
20
US
CD19x22 CAR T Cells
University of Colorado, Denver
Non-Hodgkin Lymphoma
12/24
12/25

Download Options